Valuation: Highnoon Laboratories Limited

Market Cap 54.07B 194M 170M 157M 145M 276M 18.56B 280M 1.88B 736M 9.12B 730M 714M 31.57B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 54.07B 194M 170M 157M 145M 276M 18.56B 280M 1.88B 736M 9.12B 730M 714M 31.57B EV / Sales 2026 *
1.78x
EV / Sales 2027 * 1.58x
Free-Float
50.02%
Yield 2026 *
4.41%
Yield 2027 * 5.1%
1 day+1.72%
1 week-1.38%
Current month+1.78%
1 month+5.32%
3 months+4.90%
6 months-2.97%
Current year-0.19%
1 week 1,000
Extreme 1000
1,075
1 month 960
Extreme 960
1,075
Current year 755.56
Extreme 755.56
1,101
1 year 755.56
Extreme 755.56
1,241
3 years 330
Extreme 330
1,241
5 years 322.1
Extreme 322.1
1,241
10 years 127.86
Extreme 127.8558
1,241
Manager TitleAgeSince
Chief Executive Officer - 2015-03-31
Chief Executive Officer 63 1995-12-31
Director of Finance/CFO - 2020-03-31
Director TitleAgeSince
Chairman - 2025-06-30
Chairman - 2012-09-06
Chairman - -
Change 5-day change 1-year change 3-year change Capi.($)
+1.72%-1.38%-0.91%+185.95% 191M
-2.54%-1.09%+50.13%+161.94% 1,085B
-0.36%-0.39%+63.81%+61.94% 624B
-1.36%-3.27%+26.37%+83.23% 442B
-0.92%-1.41%+27.68%+26.60% 332B
-3.29%-11.00%+21.08%+26.39% 277B
-0.07%-2.89%+25.21%+44.81% 282B
+0.66%-1.42%-29.26%-39.30% 217B
+0.02%-0.85%+20.96%+61.67% 196B
-2.62%+1.45%+14.80%+73.72% 167B
Average -0.87%-2.05%+21.99%+68.70% 362.21B
Weighted average by Cap. -1.40%-1.06%+35.40%+81.68%

Financials

2026 *2027 *
Net sales 30.4B 109M 95.64M 88.19M 81.6M 155M 10.44B 157M 1.06B 414M 5.12B 410M 402M 17.75B 34.16B 123M 107M 99.12M 91.71M 174M 11.73B 177M 1.19B 465M 5.76B 461M 451M 19.95B
Net income - -
Net Debt - -
Logo Highnoon Laboratories Limited
Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling, and marketing of pharmaceutical and related consumer products. Its product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Cuziper, Hitica, Apiban, Misar, and Herbesser. Its metabolic products include Daploz, Tagip, Diajard, and Nylomet. Its gastroenterology products include Rabecid, Racedo, Skilax, and Fosbu. Its musculoskeletal products include Kydor, Hilin, Airtal, and Tamadol. Its anti-infective products include Evacef, Maxum, Efix, and Cefia. Its obstetrics and gynecology products include Hitase. Its pediatrics product includes Tres Orix Forte. Its allergy products include Leviva and Kestine. Its respiratory products include Combivair Forte, Glynvair, Betatec, Ultivair, and Montit. Its urology products include Prostam.
Employees
2,563
Date Price Change Volume
26-07-09 PKR 1,020.54 +1.72% 14,336
26-07-09 PKR 1,003.28 -0.70% 47,184
26-07-08 PKR 1,010.35 -3.76% 40,627
26-07-07 PKR 1,049.80 -1.00% 44,579
26-07-06 PKR 1,060.42 +0.55% 33,616
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1,020.54PKR
Average target price
1,121.00PKR
Spread / Average Target
+9.84%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. HINOON Stock